BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Waldenström’s Macroglobulinemia at the 2016 American Society of Hematology Annual Meeting Dec 5, 2016 10:00PM

WALTHAM, Mass., Dec. 05, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE) a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today presented updated clinical data from an ongoing Phase I study of BTK inhibitor BGB-3111 in patients with Waldenström’s macroglobulinemia (WM) at the 2016 American Society of Hematology (ASH) Annual Meeting in San Diego, California. The updated... (continue reading...)


Union Station Fire Highlights the Importance of Professional Fire Prevention Systems, says Fire Protection Group, Inc. Dec 5, 2016 10:00PM

Los Angeles, CA (PRWEB) December 05, 2016

According to a November 19 article published on ABC7, firefighters were called to put out a fire at the historic Union Station in Downtown Los Angeles that originally started in a dumpster. Southern California-based fire prevention agency Fire Protection Group Inc. (FPG Inc.) notes that valuable property, whether brand new or historic, can be protected from the worst impacts of a blaze with the help of skilled professional fire... (continue reading...)


Ocwen Successfully Extends Corporate Debt Maturities to December 2020 and December 2022 Dec 5, 2016 09:55PM

WEST PALM BEACH, Fla., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation, (NYSE: OCN) (“Ocwen” or the “Company”), a leading financial services holding company, today announced the completion of the settlement of the previously announced Exchange Offer by its subsidiary Ocwen Loan Servicing, LLC (“OLS”) pursuant to which OLS issued $346.9 million aggregate principal amount of 8.375% Senior Secured Second Lien Notes due 2022 (the “New Second... (continue reading...)


Stone Energy Corporation Announces Amethyst Operational Update Dec 5, 2016 09:42PM

LAFAYETTE, La., Dec. 5, 2016 /PRNewswire/ -- Stone Energy Corporation (NYSE: SGY) ("Stone") today announced an operational update on its Amethyst well.

As previously reported, production from Stone's Amethyst well (the "Well") was shut in during late April 2016 to allow for a technical evaluation.  During the first week of November, we initiated acid stimulation work and intermittently flowed the Well during the month of November at a rate of 10 – 15 million cubic... (continue reading...)


Nordic Nanovector: Betalutin® in Combination with rituximab Demonstrates Synergistic Anti-Tumour Effect in Preclinical non-Hodgkin Lymphoma Model Dec 5, 2016 09:40PM

Data presented at the ASH Annual Meeting

OSLO, Norway--(BUSINESS WIRE)-- Nordic Nanovector ASA (OSE: NANO) announces that it has presented a poster describing the synergistic therapeutic effect of Betalutin® (177Lu-satetraxetan-lilotomab) in combination with rituximab in a preclinical model of non-Hodgkin lymphoma (NHL) (abstract 4189). The new data was presented at the 58th Annual American Society of Hematology ... (continue reading...)


More Press Releases

View Older Stories

Dec 5, 2016 09:32PM Agnico Eagle announces investment in G4G Capital Corp. (proposed to be renamed White Gold Corp.)
Dec 5, 2016 09:32PM The Luminaires Group Acquires Luminis
Dec 5, 2016 09:29PM Havas Achieves 7X Faster Performance for IBM Cloud Services with Aryaka's Global SD-WAN
Dec 5, 2016 09:30PM Kiadis Pharma presents positive 1-year follow-up data of its pivotal Phase II trial with ATIR101™
Dec 5, 2016 09:20PM New Ibrutinib (IMBRUVICA®) Phase 2 Data Demonstrate Promise in Relapsed/Refractory Marginal Zone Lymphoma (MZL), a Rare, Incurable Type of Non-Hodgkin's Lymphoma
Dec 5, 2016 09:18PM Former Googler Joins Ezoic as New Vice President of Global Partnerships
Dec 5, 2016 09:15PM Starwood Property Trust Announces Pricing of Common Stock Offering
Dec 5, 2016 09:15PM New Phase 2 Data Show Nearly Half of Patients with Relapsed/Refractory Marginal Zone Lymphoma (MZL) Respond to Treatment with Ibrutinib (IMBRUVICA®)
Dec 5, 2016 09:15PM Verastem Presents Phase 2 DYNAMO® Clinical Data at ASH 2016 Annual Meeting
Dec 5, 2016 09:11PM REGI U.S., Inc.: Engineering Progress Update for RadMax Technologies
Dec 5, 2016 09:05PM FYI's Hit Series "Seven Year Switch" Returns With Season Two on Tuesday, January 3 at 8pm ET
Dec 5, 2016 09:00PM Actinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual Meeting
Dec 5, 2016 09:00PM Infortrend's EonStor GS Wins "Disk/Hybrid Product of the Year" at Storage Magazine's Storage Awards
Dec 5, 2016 09:00PM Renowned Japanese Duo AUN Enthrall at Daiwa House's Japanese Music Festival
Dec 5, 2016 09:00PM Cornerstone Pharmaceuticals, Inc. Presents Phase I Data on CPI-613 in Acute Myeloid Leukemia (AML) and T-Cell Non-Hodgkin's Lymphoma (T-cell NHL) at ASH 2016
Dec 5, 2016 08:59PM Love, Auto Parts and Next Day Delivery
Dec 5, 2016 08:51PM New Research: Cracking the Code: Adapting a B2B Marketing Strategy for the Complex Prospect Journey
Dec 5, 2016 08:45PM TransFirst Media, Inc. Partners with Tourism Media Mogul VS Media Group to be Their Exclusive Advertising Distribution Partner
Dec 5, 2016 08:33PM VIMaec is Formed by Key Construction Industry Leaders
Dec 5, 2016 08:32PM Third-generation drag racer Troy Coughlin Jr. humbled by Top Fuel opportunity
Dec 5, 2016 08:30PM Avamere's Newest Transitional Care Facility Brings Advance Short-Term Nursing and Rehabilitation Options to Tacoma
Dec 5, 2016 08:27PM Uranium Resources to Retire $8M Indebtedness with RCF
Dec 5, 2016 08:20PM CORRECTION - 1-Page Announces Hiring of Peter Kent as COO/CFO
Dec 5, 2016 08:13PM Golden Leaf Holdings Issues Shares to Settle Debt
Dec 5, 2016 08:10PM Zimmer Biomet Announces the Early Tender Results and Upsizing of Its Cash Tender Offers for Certain Outstanding Debt Securities
Dec 5, 2016 08:10PM Stoel Rives Attorney Honored for Support of Seattle Asian-American Community
Dec 5, 2016 08:03PM Wayne Homes' Annual Not-So-Random Acts of Kindness Program Begins
Dec 5, 2016 08:02PM Announcing Wealth Matters: Special Report
Dec 5, 2016 08:01PM Greenberg Traurig Serves as Lead Counsel in Bio Pappel's U.S. $409 Million-Equivalent Secured, Syndicated Dual-Currency Credit Facility
Dec 5, 2016 08:00PM Greenberg Traurig's Jonathan A. Beckham to Speak at ACC National Capital Chapter Program
Dec 5, 2016 08:00PM With Terror Attacks on the Rise, Florida Technical College Offers Survival Program Free of Cost as a Community Service
Dec 5, 2016 08:00PM Dylan Moses of IMG Academy Wins National High School Butkus Award(R)
Dec 5, 2016 07:54PM Galaxy Golf Enters a New Dimension with Oculus Touch
Dec 5, 2016 07:45PM The World's First Hybrid Fractional Laser Coming to Renowned Austin Plastic Surgeon
Dec 5, 2016 07:45PM Greenberg Traurig's Justin J. Prochnow Speaks at BevNET Live!
Dec 5, 2016 07:44PM Precision Medicine Takes Center Stage at Connected Health Conference
Dec 5, 2016 07:44PM Quartus Engineering Relocates San Diego Headquarters
Dec 5, 2016 07:30PM Greenberg Traurig Shareholder Ilene Katz Kobert to Speak at Dade County Bar Association's 'ABC's of Commercial Leasing'
Dec 5, 2016 07:30PM Agios Announces New Clinical Data from Dose-Escalation Portion of Phase 1 Trial of Single Agent AG-120 Showing Durable Molecular Responses in Patients with Advanced Hematologic Malignancies
Dec 5, 2016 07:30PM LGI Homes, Inc. Reports November 2016 Home Closings
Dec 5, 2016 07:30PM Daratumumab (DARZALEX®) Combination Therapy Showed Consistent Clinical Benefit for Previously-Treated Patients with Multiple Myeloma
Dec 5, 2016 07:30PM Combined Analysis of Oral Epigenetic Therapy, CC-486, Demonstrated Hematologic Responses in Patients Who Received Prior Epigenetic Hypo-Methylating Agents (HMA)
Dec 5, 2016 07:30PM Seattle Genetics and Bristol-Myers Squibb Highlight First Data from Phase 1/2 Study Evaluating ADCETRIS® (Brentuximab Vedotin) in Combination with Opdivo (nivolumab) in Relapsed or Refractory Hodgkin
Dec 5, 2016 07:30PM Sangamo BioSciences Presents Hemophilia A Program Data At The 2016 American Society Of Hematology Meeting
Dec 5, 2016 07:30PM KEYTRUDA® (pembrolizumab) Treatment Results in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) Presented at 58th Annual Meeting of the American Society of Hematology
Dec 5, 2016 07:30PM bluebird bio Provides Updates on HSC Gene Therapy Programs
Dec 5, 2016 07:27PM AstraQom International Announces Major Expansion Into Brazil with AstraQom Brazil's New Corporate Offices in Rio De Janeiro
Dec 5, 2016 07:26PM Forum Energy Technologies Announces Pricing of Public Offering of Common Stock
Dec 5, 2016 07:21PM Family Care Partners Acquires Wagener Medical Center
Dec 5, 2016 07:16PM Hourglass Tummy Tuck: The Next Generation in Body Contouring
View Older Stories